Association of opioid agonist treatment with all-cause mortality and specific causes of death among people with opioid dependence: a systematic review and meta …

T Santo, B Clark, M Hickman, J Grebely… - JAMA …, 2021 - jamanetwork.com
Importance Mortality among people with opioid dependence is higher than that of the
general population. Opioid agonist treatment (OAT) is an effective treatment for opioid …

Trends and barriers of medication treatment for opioid use disorders: a systematic review and meta-analysis

M Hutchison, BS Russell, A Leander… - Journal of Drug …, 2023 - journals.sagepub.com
Adherence to and retention in Medication Treatment for Opioid Use Disorders (MOUD)
persist. We systematically reviewed trends of USA MOUD adherence, retention, and barriers …

Psychiatric comorbidity and treatment outcomes in patients with opioid use disorder: results from a multisite trial of buprenorphine-naloxone and methadone

Y Zhu, LJ Mooney, C Yoo, EA Evans… - Drug and alcohol …, 2021 - Elsevier
Background Individuals treated for opioid use disorder (OUD) have high rates of psychiatric
disorders potentially diminishing treatment outcomes. We examined long-term treatment …

Mental health and psychosocial needs of patients being treated for opioid use disorder in a primary care residency clinic

SA Hooker, MD Sherman… - Journal of primary …, 2020 - journals.sagepub.com
Purpose: Primary care is an ideal setting to deliver efficacious treatments for opioid use
disorder (OUD). Primary care providers need to be aware of other concerns patients with …

Adherence to buprenorphine: an analysis of prescription drug monitoring program data

LN Pizzicato, JK Hom, M Sun, CC Johnson… - Drug and Alcohol …, 2020 - Elsevier
Background Although buprenorphine is an evidence-based treatment for opioid use
disorder (OUD), many individuals discontinue treatment soon after starting. This study …

[HTML][HTML] Opioid agonist therapy trajectories among street entrenched youth in the context of a public health crisis

V Giang, M Thulien, R McNeil, K Sedgemore… - SSM-Population …, 2020 - Elsevier
North America is in the midst of an overdose crisis that is having devastating effects among
street entrenched youth (< 30 years of age). Opioid agonist therapy (OAT) is a cornerstone of …

Medication-assisted treatment for opioid use disorder within a 12-step based treatment center: Feasibility and initial results

AA Klein, MD Seppala - Journal of Substance Abuse Treatment, 2019 - Elsevier
Rationale Opioid overdose deaths and healthcare costs associated with opioid use disorder
(OUD) continue to escalate while the majority of addiction treatment providers in the United …

The phenomics and genetics of addictive and affective comorbidity in opioid use disorder

PJ Freda, JH Moore, HR Kranzler - Drug and alcohol dependence, 2021 - Elsevier
Opioid use disorder (OUD) creates significant public health and economic burdens
worldwide. Therefore, understanding the risk factors that lead to the development of OUD is …

[HTML][HTML] Co-occurring psychiatric disorders and disparities in buprenorphine utilization in opioid use disorder: an analysis of insurance claims

KY Xu, V Huang, AR Williams, CE Martin… - Drug and Alcohol …, 2023 - Elsevier
Background As the overdose crisis continues in the US and Canada, opioid use disorder
(OUD) treatment outcomes for people with co-occurring psychiatric disorders are not well …

Treatment outcomes in individuals diagnosed with comorbid opioid use disorder and Posttraumatic stress disorder: A review

S Meshberg-Cohen, RR MacLean, AMS Martin… - Addictive …, 2021 - Elsevier
Objectives Opioid use disorder (OUD) is a public health emergency. Evidence suggests that
posttraumatic stress disorder (PTSD) is common among individuals with OUD; however, few …